Medroxyprogesterone Acetate | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Medroxyprogesterone Acetate
Health Canada Patents

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

Coral Medroxyprogesterone Acetate

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Medroxyprogesterone Acetate

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

32 API Suppliers, 18 USDMF, 7 CEP/COS, 1 JDMF, 5 KDMF, 14 NDC API, 18 Listed Suppliers, $ API Reference Price

32 API Suppliers
18 USDMF
7 CEP/COS
1 JDMF
5 KDMF
14 NDC API
18 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

INTERMEDIATES

4 Intermediate Suppliers

4 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

151 FDF Dossiers, 41 FDA Orange Book, 48 Europe, 14 Canada, 21 Australia, 15 South Africa, 12 Listed Dossiers

151 FDF Dossiers
41 FDA Orange Book
48 Europe
14 Canada
21 Australia
15 South Africa
12 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 10MG, TABLET;ORAL - 2.5MG, TABLET;ORAL - 5MG, INJECTABLE;INJECTION - 100MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 400MG/ML, INJECTABLE;INJECTION - 150MG/ML

TABLET;ORAL - 10MG
TABLET;ORAL - 2.5MG
TABLET;ORAL - 5MG
INJECTABLE;INJECTION - 100MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
INJECTABLE;INJECTION - 400MG/ML
INJECTABLE;INJECTION - 150MG/ML

RELATED EXCIPIENT COMPANIES

3 Evonik, 4 SPI Pharma, 2 Seqens, 3 DKSH, 5 Faran Shimi Pharmaceutical, 1 Boai NKY Pharmaceuticals Ltd, 3 Gangwal Healthcare, 5 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 9 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 27 BASF, 1 Clariant, 3 Corel Pharma Chem, 4 DFE Pharma, 2 Finar, 10 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 2 Ingredion Pharma Solutions, 20 Kerry, 12 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 1 Novo Excipients, 2 Pharmatrans-Sanaq, 5 Pluviaendo, 2 Prachin Chemical, 15 Roquette, 8 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 10 Sigachi Industries, 2 Valens Pharmachem, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

54 Fillers, Diluents & Binders, 30 Coating Systems & Additives, 26 Solubilizers, 22 Controlled & Modified Release, 21 Thickeners and Stabilizers, 20 Direct Compression, 18 Granulation, 18 Lubricants & Glidants, 17 Parenteral, 16 Topical, 12 Film Formers & Plasticizers, 11 Taste Masking, 11 Co-Processed Excipients, 8 Disintegrants & Superdisintegrants, 5 Emulsifying Agents, 5 Chewable & Orodispersible Aids, 4 Surfactant & Foaming Agents, 3 Coloring Agents, 3 Rheology Modifiers, 1 API Stability Enhancers

54 Fillers, Diluents & Binders
30 Coating Systems & Additives
26 Solubilizers
22 Controlled & Modified Release
21 Thickeners and Stabilizers
20 Direct Compression
18 Granulation
18 Lubricants & Glidants
17 Parenteral
16 Topical
12 Film Formers & Plasticizers
11 Taste Masking
11 Co-Processed Excipients
8 Disintegrants & Superdisintegrants
5 Emulsifying Agents
5 Chewable & Orodispersible Aids
4 Surfactant & Foaming Agents
3 Coloring Agents
3 Rheology Modifiers
1 API Stability Enhancers

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 20 NEWS #PharmaBuzz

1 DATA COMPILATION #PharmaFlow
20 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 39 Finished Drug Prices

3 US Medicaid Prescriptions
39 Finished Drug Prices

MARKET PLACE

8 APIs, 6 FDF Dossiers

8 APIs
6 FDF Dossiers

PATENTS & EXCLUSIVITIES

1 Health Canada Patents

1 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 3 USP, 4 Others

3 EDQM
3 USP
4 Others

$ API Ref.Price (USD/KG) : 924 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

1 All

01 1Pfizer Canada Inc.

filter Patent Reset all filters

1 All

01 12409059

filter Product Reset all filters

1 All

01 1Medroxyprogesterone Acetate

filter Dosage Reset all filters

1 All

01 1Suspension

filter Exp Date Reset all filters

1 All

01 12021-04-25

Product Main Page

01

Pfizer Canada Inc.

Medroxyprogesterone Acetate

BioAsia

Not Confirmed

Pfizer Canada Inc.

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2021-04-25

Date Granted : 2006-04-18

Medroxyprogesterone Acetate

Brand Name : DEPO-PROVERA SC

Patent Number : 2409059

Filing Date : 2001-04-25

Strength per Unit : 104 mg / 0.65 mL

Dosage Form : Suspension

Human Or VET : Human

Route of Administration : Subcutaneous

Patent Expiration Date : 2021-04-25

Date Granted : 2006-04-18

Portfolio PDF

Product Web Link

Digital Content

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!